Gliminyle-M2 Tablet PR
By Gliminyle-M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Erinyle Pharma
H.No. 11-7-196, Huda Colony, Saroornagar, Hyderabad, Telangana 500032

Expires on or after
January, 2027

liver
Gliminyle-M2 Tablet PR should be used carefully by individuals with liver disease. Adjusting the dose of Gliminyle-M2 Tablet PR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Gliminyle-M2 Tablet PR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Gliminyle-M2 Tablet PR.

kidney
Caution should be exercised with Gliminyle-M2 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Gliminyle-M2 Tablet PR.

driving
When taking Gliminyle-M2 Tablet PR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Gliminyle-M2 Tablet PR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Gliminyle-M2 Tablet PR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹165
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024